Eight new drugs that are able to stimulate the nervous system were discovered by a research team at UC San Francisco recently. The team utilized a novel screening platform and examined the cellular effects of 1,000 chemical compounds. The scientists believe the discovery may impact the treatment of the tissue…
Experimental treatment
News
Compassionate Use Trial of Innate Immunotherapeutics’ Multiple Sclerosis Drug Shows Positive Results
Australian biotechnology company Innate Immunotherapeutics’ trial for a drug designed to treat secondary progressive multiple sclerosis (SPMS) has produced positive results. Innate’s experimental MIS416 has revealed benefits to the majority of SPMS patients who were prescribed it as a “compassionate use drug,” given the total lack of…
Following the promising results of prior trials, Receptos, Inc., a biopharmaceutical company engaged in the treatment of immune and metabolic diseases, announced that the Phase 2 portion of the RADIANCE trial has met the primary endpoint, a reduction in MRI brain lesion activity in patients with relapsing multiple sclerosis…
Recommended Posts
- Looking forward to fall amid the summer heat
- Vaccine slashes risk of shingles in adults with MS in US, study finds
- Social, economic factors linked to poorer cognitive performance in MS
- Early high-efficacy MS drugs cut relapse risk, not progression
- Pilot study compares effects of 2 diet plans on sleep and appetite in MS